Atrial Fibrillation Market By Top Key Players ABBOTT LABORATORIES , JOHNSON & JOHNSON , ATRICURE, INC. , MICROPORT SCIENTIFIC CORPORATION

Atrial fibrillation is of the most frequently occurred arrhythmia that causes problem with the rhythm of the heart (such as too slow or too fast heart beat). During atrial fibrillation, heart beats are irregular and it can be too slow or too fast as compared to the regular heartbeat. Atrial fibrillation can increase the rate of heart stroke, cause chest pain or even heart attack especially if the heart beat is too fast.

Get Sample Copy Of This Report @ https://www.bigmarketresearch.com/request-sample/779162?utm_source=op&utm_medium=Srbh

During atrial fibrillation, both the chambers (upper and lower) beat irregularly, chaotically, and out of coordination of the heart. Shortness of breath, weakness, chest pain, dizziness, lightheadedness or fainting and heart palpitation are the common symptoms of atrial fibrillation. In addition, atrial fibrillation may lead to formation of blood clots in the heart, which may circulate to other organs. In atrial fibrillation, for altering the electrical system of heart, treatments such as medications and interventions are provided.

Atrial fibrillation market is in its emerging state as the prevalence of atrial fibrillation is growing rapidly along with the increase in aging population. According to American Heart Association, 33.5 million individuals (0.5% of the world’s population) were with atrial fibrillation in 2013. Also, technological advancement towards surgical devices for atrial fibrillation fuels the market growth. However, pitfalls such as stringent government policies, high cost of atrial fibrillation treatment, and dearth of skilled professionals and technicians hinders the market growth.

The world atrial fibrillation market has been segmented based on devices and region. Based on devices, the market is segmented into surgical devices and non-surgical devices. Surgical devices are further sub-classified into maze surgery and catheter ablation. Non-surgical devices are further sub-divided into electric cardioversion, diagnostic catheters, mapping and recording systems, cardiac monitors, access devices, left atrial appendage, and closure devices and intracardiac echocardiography (ICE) Systems. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

The key strategies adopted are product launch, collaboration, and merger & acquisition. For instance, Abbott acquired Kalila Medical, Inc. (U.S.), which helped Abbott develop next generation technologies that are useful to treat cardiac disorders such as atrial fibrillation. Biosense Webster, Inc. acquired Coherex Medical, Inc. (U.S.), which helped Biosense Webster, Inc. to strengthen its medical devices product portfolio.

KEY MARKET BENEFITS:

In-depth analysis of the market is conducted based on market estimations of the key segments for the period 2014-2022
Comprehensive analysis of factors that drive and restrict the growth of the world atrial fibrillation market is provided in the report
Exhaustive analysis of the world atrial fibrillation market by different segments helps understand the different aspects of atrial fibrillation that are currently used along with the variants that would gain prominence in the future
Competitive intelligence of leading manufacturers and distributors of atrial fibrillation market interprets the competitive scenario across various geographies
Key market players within the atrial fibrillation market are profiled in the report and their strategies are analyzed thoroughly, which predicts competitive outlook of the world market.

Get Purchase Inquiry @ https://www.bigmarketresearch.com/purchase-enquiry/779162?utm_source=op&utm_medium=Srbh

KEY MARKET SEGMENT:

By Devices : Surgical Devices,Maze Surgery,Catheter Ablation,Radiofrequency Catheter Ablation,Conventional RF Ablation Catheters,Irrigated-tip RF Ablation Catheters,Cryoablation,Microwave Based Catheter Ablation,Laser Based Catheter Ablation,Navigational Advanced Mapping Accessories,Non-Surgical Devices,Electric Cardioversion,Diagnostic Catheters,Conventional Diagnostic Catheters,Fixed Diagnostic Catheters,Steerable Diagnostic Catheters,Advanced Diagnostic Catheters,Mapping and Recording Systems,Cardiac Monitors,Access Devices,Left Atrial Appendage and Closure Devices,Intracardiac Echocardiography (ICE) Systems

By Geography

North America
Europe
Asia-Pacific
LAMEA

KEY PLAYERS

Abbott Laboratories,Johnson & Johnson,MicroPort Scientific Corporation,Boston Scientific Corporation,St. Jude Medical, Inc.,Medtronic plc,Biotronik SE & Co. KG,Koninklijke Philips N.V.,Siemens AG,AtriCure Inc.

Other players in the value chain include

Biosense Webster, Inc.,CardioFocus, Inc.,CathEffects Inc.,CathRx Ltd.,EndoPhotonix, Inc.,Japan Lifeline Co.,Osypka AG,Pioneer Medical Devices AG,GE Healthcare,TZ Medical, Inc.

*Profiles of these players are not included. The same will be included on request.

Get Purchase Discount @ https://www.bigmarketresearch.com/request-for-discount/779162?utm_source=op&utm_medium=Srbh

About Us:

Big Market Research has a range of research reports from various publishers across the world.
Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:

Mr. Abhishek Paliwal
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Direct:+1-971-202-1575
Toll Free:+1-800-910-6452
email help@bigmarketresearch.com

This release was published on openPR.